Currie Mark G 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed Jun 22, 2023
Insider Transaction Report
Form 4
Currie Mark G
Chief Scientific Officer
Transactions
- Award
Class A Common Stock
2023-06-20+22,350→ 544,108 total
Footnotes (1)
- [F1]The restricted stock, granted pursuant to the Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2023, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.